Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 34
Filter
Add more filters

Publication year range
1.
J Biomed Mater Res A ; 109(12): 2545-2555, 2021 12.
Article in English | MEDLINE | ID: mdl-34173706

ABSTRACT

Bone repair in elderly mice has been shown to be improved or negatively impacted by supplementing the highly osteogenic bone morphogenetic protein-2 (BMP-2) with fibroblast growth factor-2 (FGF-2). To better predict the outcome of FGF-2 supplementation, we investigated whether endogenous levels of FGF-2 play a role in optimal dosing of FGF-2 for augmenting BMP-2 activity in elderly mice. In vivo calvarial bone defect studies in Fgf2 knockout mice with wildtype controls were conducted with the growth factors delivered in a highly localized manner from a biomimetic calcium phosphate/polyelectrolyte multilayer coating applied to a bone graft substitute. Endogenous FGF-2 levels were measured in old mice versus young and found to decrease with age. Optimal dosing for improving bone defect repair correlated with levels of endogenous FGF-2, with a larger dose of FGF-2 required to have a positive effect on bone healing in the Fgf2 knockout mice. The same dose in wildtype old mice, with higher levels of FGF-2, promoted chondrogenesis and increased osteoclast activity. The results suggest a personalized medicine approach, based on a knowledge of endogenous levels of FGF-2, should guide FGF-2 supplementation in order to avoid provoking excessive bone resorption and cartilage formation, both of which inhibited calvarial bone repair.


Subject(s)
Bone Morphogenetic Protein 2/pharmacology , Bone and Bones/abnormalities , Fibroblast Growth Factor 2/genetics , Fibroblast Growth Factor 2/pharmacology , Skull/drug effects , Skull/growth & development , Aging/pathology , Animals , Biomimetics , Bone Resorption , Bone Transplantation , Calcium Phosphates , Cartilage/growth & development , Coated Materials, Biocompatible , Drug Delivery Systems , Female , Fracture Healing , Mice , Mice, Knockout
2.
Nat Med ; 27(4): 647-652, 2021 04.
Article in English | MEDLINE | ID: mdl-33737749

ABSTRACT

Many observational studies and some randomized trials demonstrate how fetal growth can be influenced by environmental insults (for example, maternal infections)1 and preventive interventions (for example, multiple-micronutrient supplementation)2 that can have a long-lasting effect on health, growth, neurodevelopment and even educational attainment and income in adulthood3. In a cohort of pregnant women (n = 3,598), followed-up between 2012 and 2019 at six sites worldwide4, we studied the associations between ultrasound-derived fetal cranial growth trajectories, measured longitudinally from <14 weeks' gestation, against international standards5,6, and growth and neurodevelopment up to 2 years of age7,8. We identified five trajectories associated with specific neurodevelopmental, behavioral, visual and growth outcomes, independent of fetal abdominal growth, postnatal morbidity and anthropometric measures at birth and age 2. The trajectories, which changed within a 20-25-week gestational age window, were associated with brain development at 2 years of age according to a mirror (positive/negative) pattern, mostly focused on maturation of cognitive, language and visual skills. Further research should explore the potential for preventive interventions in pregnancy to improve infant neurodevelopmental outcomes before the critical window of opportunity that precedes the divergence of growth at 20-25 weeks' gestation.


Subject(s)
Child Development , Fetus/embryology , Skull/embryology , Skull/growth & development , Cephalometry , Female , Humans , Infant , Infant, Newborn , Morbidity , Pregnancy
3.
Arch Oral Biol ; 117: 104828, 2020 Sep.
Article in English | MEDLINE | ID: mdl-32673818

ABSTRACT

OBJECTIVE: The present study aimed to investigate the effects of hyperbaric oxygen (HBO) treatment on calvarial bone regeneration in young and adult mice. METHODS: Calvarial defects of 6.0 mm diameter were created in sixteen 3-week (young) and sixteen 32-week old (adult) mice. The mice were divided into two groups of eight animals each (HBO-treated and control). The 90-min HBO treatment at 2.5 absolute atmospheric pressure and 100 % oxygen was performed for five days a week for 12 weeks. After 2-weeks from the operation, micro-computerized tomography and video microscopy were used to evaluate the regenerated bone volume and microcirculation every two weeks. The protein concentrations of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) in exudates of the calvarial tissue field were measured at 1, 2, 3, and 4 weeks after surgery. After 12 weeks, histochemical examination of regenerated calvarial bone was conducted. RESULTS: Regenerated bone was formed earlier in young mice than in adult mice treated with HBO. HBO stimulates angiogenesis in the periosteum around regenerated bone area in both young and adult mice at 2 weeks. VEGF concentrations in the calvarial tissue field were lower in the HBO group than in the control 1 week after operation, although bFGF were higher till the 2nd week in the HBO group than in the control. CONCLUSIONS: HBO accelerates bone regeneration earlier in young mice than in adult mice. In the HBO-treated group, bFGF expression was promoted at an early stage, although the expression of VEGF was inhibited.


Subject(s)
Bone Regeneration , Hyperbaric Oxygenation , Skull/growth & development , Age Factors , Animals , Fibroblast Growth Factor 2 , Mice , Oxygen , Skull/diagnostic imaging , Vascular Endothelial Growth Factor A
4.
Article in English | MEDLINE | ID: mdl-28457946

ABSTRACT

Bone disorders affect millions of people worldwide and available therapeutics have a limited efficacy, often presenting undesirable side effects. As such, there is a need for novel molecules with bone anabolic properties. The aim of this work was to establish a rapid, reliable and reproducible method to screen for molecules with osteogenic activities, using the zebrafish operculum to assess bone formation. Exposure parameters were optimized through morphological analysis of the developing operculum of larvae exposed to calcitriol, a molecule with known pro-osteogenic properties. An exposure of 3days initiated at 3days post-fertilization was sufficient to stimulate operculum formation, while not affecting survival or development of the larvae. Dose-dependent pro- and anti-osteogenic effects of calcitriol and cobalt chloride, respectively, demonstrated the sensitivity of the method and the suitability of the operculum system. A double transgenic reporter line expressing fluorescent markers for early and mature osteoblasts was used to gain insights into the effects of calcitriol and cobalt at the cellular level, with osteoblast maturation shown to be stimulated and inhibited, respectively, in the operculum of exposed fish. The zebrafish operculum represents a consistent, robust and rapid screening system for the discovery of novel molecules with osteogenic, anti-osteoporotic or osteotoxic activity.


Subject(s)
Drug Evaluation, Preclinical/methods , Osteogenesis/drug effects , Skull/growth & development , Toxicity Tests/methods , Zebrafish , Animals , Animals, Genetically Modified , Calcification, Physiologic/drug effects , Calcitriol/pharmacology , Cobalt/toxicity , Dose-Response Relationship, Drug , Female , Genetic Markers , Larva/drug effects , Larva/growth & development , Male , Osteoblasts/drug effects , Skull/drug effects , Zebrafish/genetics
5.
Sci Rep ; 6: 33316, 2016 09 13.
Article in English | MEDLINE | ID: mdl-27622425

ABSTRACT

The Neolithic transition brought about fundamental social, dietary and behavioural changes in human populations, which, in turn, impacted skeletal morphology. Crania are shaped through diverse genetic, ontogenetic and environmental factors, reflecting various elements of an individual's life. To determine the transition's effect on cranial morphology, we investigated its potential impact on the face and vault, two elements potentially responding to different influences. Three datasets from geographically distant regions (Ukraine, Iberia, and the Levant plus Anatolia) were analysed. Craniometric measurements were used to compare the morphology of pre-transition populations with that of agricultural populations. The Neolithic transition corresponds to a statistically significant increase only in cranial breadth of the Ukrainian vaults, while facial morphology shows no consistent transformations, despite expected changes related to the modification of masticatory behaviour. The broadening of Ukrainian vaults may be attributable to dietary and/or social changes. However, the lack of change observed in the other geographical regions and the lack of consistent change in facial morphology are surprising. Although the transition from foraging to farming is a process that took place repeatedly across the globe, different characteristics of transitions seem responsible for idiosyncratic responses in cranial morphology.


Subject(s)
Face/anatomy & histology , Skull/anatomy & histology , Agriculture/history , Cephalometry/history , History, Ancient , Humans , Skull/growth & development , Ukraine
6.
Orthod Craniofac Res ; 19(4): 222-233, 2016 Nov.
Article in English | MEDLINE | ID: mdl-27506322

ABSTRACT

OBJECTIVES: There is controversy regarding the relationship between mandibular position and alterations of the cranial base that provoke a more anterior location of the glenoid fossa. Artificially deformed skulls display marked alterations of the cranial base. This study evaluates mandibular changes as function of the morphology of the cranial base in these skulls. MATERIAL AND METHODS: A geometric morphometric study was performed on lateral cephalometric X-rays of three groups of skulls: 32 with anteroposterior deformity, 17 with circumferential deformity and 39 with no apparent deformity. RESULTS: In artificially deformed skulls, the cranial base was deformed causing the mandibular condyle to be in a more anterior position. There was a complete remodelling of the mandible involving narrowing and elongation of the mandibular ramus, rotation of the corpus of the mandible and increased vertical height of the symphysis. Forward displacement did not occur. Integration between mandible and cranial base is not altered by deformation of the skull. CONCLUSIONS: Deformity of the cranial vault exerts an influence on the mandible, supporting the theory of modular units in complete integration. This also supports the theory that mandibular prognathism is a multifactorial result and not a direct effect of displacement of the cranial base.


Subject(s)
Cephalometry/methods , Craniofacial Abnormalities/diagnostic imaging , Image Processing, Computer-Assisted/methods , Mandible/pathology , Skull Base/pathology , Skull/diagnostic imaging , Skull/pathology , Archaeology , Craniofacial Abnormalities/ethnology , Craniofacial Abnormalities/etiology , History, Ancient , Humans , Indians, South American/ethnology , Male , Mandible/growth & development , Mandibular Condyle/pathology , Peru/ethnology , Principal Component Analysis , Prognathism/etiology , Radiography/methods , Skull/growth & development , Skull Base/growth & development
7.
EMBO Mol Med ; 8(4): 375-87, 2016 04 01.
Article in English | MEDLINE | ID: mdl-26941261

ABSTRACT

Bone anabolic agents promoting bone formation and rebuilding damaged bones would ideally overcome the limitations of anti-resorptive therapy, the current standard prescription for osteoporosis. However, the currently prescribed parathyroid hormone (PTH)-based anabolic drugs present limitations and adverse effects including osteosarcoma during long-term use. Also, the antibody-based anabolic drugs that are currently being developed present the potential limits in clinical application typical of macromolecule drugs. We previously identified that CXXC5 is a negative feedback regulator of the Wnt/ß-catenin pathway via its interaction with Dishevelled (Dvl) and suggested the Dvl-CXXC5 interaction as a potential target for anabolic therapy of osteoporosis. Here, we screened small-molecule inhibitors of the Dvl-CXXC5 interaction via a newly established in vitro assay system. The screened compounds were found to activate the Wnt/ß-catenin pathway and enhance osteoblast differentiation in primary osteoblasts. The bone anabolic effects of the compounds were shown using ex vivo-cultured calvaria. Nuclear magnetic resonance (NMR) titration analysis confirmed interaction between Dvl PDZ domain and KY-02061, a representative of the screened compounds. Oral administration of KY-02327, one of 55 newly synthesized KY-02061 analogs, successfully rescued bone loss in the ovariectomized (OVX) mouse model. In conclusion, small-molecule inhibitors of the Dvl-CXXC5 interaction that block negative feedback regulation of Wnt/ß-catenin signaling are potential candidates for the development of bone anabolic anti-osteoporosis drugs.


Subject(s)
Dishevelled Proteins/antagonists & inhibitors , Dishevelled Proteins/metabolism , Intracellular Signaling Peptides and Proteins/antagonists & inhibitors , Intracellular Signaling Peptides and Proteins/metabolism , Osteoporosis/drug therapy , Administration, Oral , Animals , DNA-Binding Proteins , Drug Evaluation, Preclinical/methods , Mice , Organ Culture Techniques , Osteoblasts/drug effects , Protein Binding/drug effects , Skull/drug effects , Skull/growth & development , Transcription Factors , Treatment Outcome , Wnt Signaling Pathway/drug effects
8.
Orthod Craniofac Res ; 18 Suppl 1: 196-206, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25865549

ABSTRACT

OBJECTIVES: Craniosynostosis, the premature fusion of cranial bones, has traditionally been described as a disease of increased bone mineralization. However, multiple mouse models of craniosynostosis display craniosynostosis simultaneously with diminished cranial bone volume and/or density. We propose an alternative hypothesis that craniosynostosis results from abnormal tissue mineralization through the downregulation of tissue-non-specific alkaline phosphatase (TNAP) enzyme downstream of activating mutations in FGFRs. MATERIAL AND METHODS: Neonatal Crouzon (FGFRC342Y/+) and wild-type (FGFR+/+) mice were injected with lentivirus to deliver a recombinant form of TNAP. Mice were sacrificed at 4 weeks postnatal. Serum was collected to test for alkaline phosphatase (AP), phosphorus, and calcium levels. Craniofacial bone fusion and morphology were assessed by micro-computed tomography. RESULTS: Injection with the TNAP lentivirus significantly increased serum AP levels (increased serum AP levels are indicative of efficient transduction and production of the recombinant protein), but results were variable and dependent upon viral lot and the litter of mice injected. Morphological analysis revealed craniofacial form differences for inferior surface (p=0.023) and cranial height (p=0.014) regions between TNAP lentivirus-injected and vehicle-injected Crouzon mice. With each unit increase in AP level, the odds of lambdoid suture fusion decreased by 84.2% and these results came close to statistical significance (p=0.068). CONCLUSION: These results suggest that TNAP deficiency may mediate FGFR2-associated craniosynostosis. Future studies should incorporate injection of recombinant TNAP protein, to avoid potential side effects and variable efficacy of lentiviral gene delivery.


Subject(s)
Alkaline Phosphatase/genetics , Craniosynostoses/therapy , Genetic Therapy , Receptor, Fibroblast Growth Factor, Type 2/genetics , Skull/pathology , Alkaline Phosphatase/blood , Animals , Calcification, Physiologic/genetics , Calcium/blood , Cephalometry/methods , Cranial Sutures/growth & development , Cranial Sutures/pathology , Craniosynostoses/physiopathology , Cysteine/genetics , Disease Models, Animal , Female , Genetic Vectors/genetics , Lentivirus/genetics , Male , Mice , Mice, Inbred BALB C , Occipital Bone/growth & development , Occipital Bone/pathology , Parietal Bone/growth & development , Parietal Bone/pathology , Phosphorus/blood , Signal Transduction/genetics , Skull/growth & development , Tyrosine/genetics , X-Ray Microtomography/methods
10.
Bauru; s.n; 2013. 113 p. ilus, tab, graf.
Thesis in Portuguese | BBO - Dentistry | ID: biblio-866942

ABSTRACT

Atualmente está aumentando o número de pessoas que usam suplementos nutricionais com a finalidade de obter melhores resultados nas suas atividades esportivas, perda de gordura, ganhos de massa muscular, ou na plasticidade do corpo. Tal fato merece atenção porque muito pouco é conhecido sobre a segurança ou eficácia destes produtos, e apenas 14% dos usuários buscam orientações com profissional da saúde sobre o uso destas substâncias. Dos mais de 200 suplementos que prometem estes efeitos apenas as suplementações de creatina HMB produzem os resultados prometidos, e o Comitê Olímpico qualifica o uso do HMB como legal. Embora a literatura atual mostre os benefícios no uso da suplementação com HMB, são poucas as informações sobre o seu efeito na morfofisiologia das fibras musculares como, por exemplo, o perfil histoenzimológico e a área dos diferentes tipos de fibras musculares. Baseado nestas informações pensou-se na realização desde trabalho para verificar se o uso de HMB provoca alterações morfológicas e histoenzimológicas nas fibras musculares dos músculos da mastigação; se estes efeitos alterariam o desenvolvimento e crescimento do esqueleto craniofacial; e se os efeitos sobre os componentes do sistema estomatognático seriam semelhantes nos indivíduos ambos os gêneros. Para realização deste estudo foram utilizados 58 ratos com idade de 60 dias, 29 animais de cada gênero, distribuídos nos seguintes grupos: Grupo Controle Inicial (GCI) que foram sacrificados no inicio do experimento; Grupo Controle Placebo (GCP) que receberam o mesmo volume do veículo do grupo experimental, e alimentação ad libitum; Grupo Experimental (GE) que receberam diariamente 0,3g/kg de HMB, por meio de gavagem e mesma quantidade de alimentos que GCP consumiu no dia anterior; Grupo Experimental Ad libitum (GEA) que receberam a mesma dose da droga, porém tiveram alimentação ad libitum. Após o tratamento, foram retiradas amostras dos músculos digástrico (ventre anterior) e masseter...


Nowadays is increasing the number of people who use nutritional supplements in order to achieve better results in their sports, fat loss, muscle gains, or the plasticity of the body. This deserves attention because very little is known about the safety or efficacy of such products, and only 14% of users seeking guidance with a health professional regarding the use of these substances. Of the more than 200 supplements that promise these effects only the HMB and creatine supplementation produce the promised effects, and the Olympic Committee qualifies the use of HMB as legal. While the literature shows benefits in the use of HMB supplementation, there is little information on its effect on muscle fibers morphophysiology as, for example, the profile and the area histoenzimológico of different types of muscle fibers. Based on this information, it was thought in performing this work to check whether the use of HMB causes morphological and histoenzimológicas changes in muscle fibers of the muscles of mastication, these effects alter the growth and development of craniofacial skeleton, and if the effects on the components of stomatognathic system would be similar in both genders individuals. For this study we used 58 rats aged 60 days, 29 animals of each gender, divided into four groups: Control Group Home (GCI) which were sacrificed at the beginning of the experiment; Placebo Control Group (GCP) that received the same volume Vehicle experimental group, and fed ad libitum; Experimental Group (EG) which received daily 0.3 g / kg of HMB, by gavage and the same amount of food they consumed on the previous day GCP; experimental group ad libitum (GEA) who received the same dose of the drug, but were fed ad libitum. After treatment, samples were taken of the digastric (anterior belly) and masseter (superficial part) for analysis histoenzimologic (m-ATPase with pre-incubations acid and alkaline) and removal of the head skeleton to taken the craniometric measures...


Subject(s)
Animals , Male , Female , Rats , Skull/growth & development , Skull , Dietary Supplements , Maxillofacial Development , Leucine/analogs & derivatives , Masticatory Muscles , Cephalometry , Rats, Wistar , Sex Factors
11.
Int J Med Sci ; 9(10): 853-61, 2012.
Article in English | MEDLINE | ID: mdl-23155359

ABSTRACT

OBJECTIVE: To assess the effect of low-level laser therapy (LLLT) on the incorporation of deep-frozen block allografts in a rabbit model. BACKGROUND DATA: Studies have shown that LLLT has beneficial effects on tissue repair and new bone formation. METHODS: Bone tissue was harvested from two rabbits, processed by deep-freezing and grafted into the calvaria of 12 animals, which were then randomly allocated into two groups: experimental (L) and control (C). Rabbits in group L were irradiated with an aluminum gallium arsenide diode laser (AlGaAs; wavelength 830 nm, 4 J/cm(2)), applied to four sites on the calvaria, for a total dose of 16 J/cm(2) per session. The total treatment dose after eight sessions was 128 J/cm(2). Animals were euthanized at 35 (n = 6) or 70 days (n = 6) postoperatively. RESULTS: Deep-freeze-processed block allografts followed by LLLT showed incorporation at the graft-host interface, moderate bone remodeling, partial filling of osteocyte lacunae, less inflammatory infiltrate in the early postoperative period, and higher collagen deposition than the control group. CONCLUSION: Optical microscopy and scanning electron microscopy showed that allograft bone processed by deep-freezing plus LLLT is suitable as an alternative for the treatment of bone defects. Use of the deep-freezing method for processing of bone grafts preserves the structural and osteoconductive characteristics of bone tissue.


Subject(s)
Low-Level Light Therapy , Osteogenesis/radiation effects , Transplantation, Homologous , Animals , Bone Transplantation , Humans , Male , Microscopy, Electron, Scanning , Rabbits , Skull/growth & development , Skull/radiation effects
12.
PLoS One ; 7(5): e36786, 2012.
Article in English | MEDLINE | ID: mdl-22586496

ABSTRACT

Osteocytes are terminally differentiated osteoblasts which reside in a mineralized extracellular matrix (ECM). The factors that regulate this differentiation process are unknown. We have investigated whether ECM mineralization could promote osteocyte formation. To do this we have utilised MLO-A5 pre-osteocyte-like cells and western blotting and comparative RT-PCR to examine whether the expression of osteocyte-selective markers is elevated concurrently with the onset of ECM mineralization. Secondly, if mineralization of the ECM is indeed a driver of osteocyte formation, we reasoned that impairment of ECM mineralization would result in a reversible inhibition of osteocyte formation. Supplementation of MLO-A5 cell cultures with ascorbic acid and phosphate promoted progressive ECM mineralization as well as temporally associated increases in expression of the osteocyte-selective markers, E11/gp38 glycoprotein and sclerostin. Consistent with a primary role for ECM mineralization in osteocyte formation, we also found that inhibition of ECM mineralization, by omitting phosphate or adding sodium pyrophosphate, a recognized inhibitor of hydroxyapatite formation, resulted in a 15-fold decrease in mineral deposition that was closely accompanied by lower expression of E11 and other osteocyte markers such as Dmp1, Cd44 and Sost whilst expression of osteoblast markers Ocn and Col1a increased. To rule out the possibility that such restriction of ECM mineralization may produce an irreversible modification in osteoblast behaviour to limit E11 expression and osteocytogenesis, we also measured the capacity of MLO-A5 cells to re-enter the osteocyte differentiation programme. We found that the mineralisation process was re-initiated and closely allied to increased expression of E11 protein after re-administration of phosphate or omission of sodium pyrophosphate, indicating an ECM mineralization-induced restoration in osteocyte formation. These results emphasise the importance of cell-ECM interactions in regulating osteoblast behaviour and, more importantly, suggest that ECM mineralization exerts pivotal control during terminal osteoblast differentiation and acquisition of the osteocyte phenotype.


Subject(s)
Calcification, Physiologic , Cell Differentiation , Extracellular Matrix , Membrane Glycoproteins/metabolism , Osteoblasts , Osteocytes , Adaptor Proteins, Signal Transducing , Animals , Calcification, Physiologic/drug effects , Calcification, Physiologic/physiology , Cell Differentiation/drug effects , Cells, Cultured , Diphosphates/pharmacology , Extracellular Matrix/drug effects , Extracellular Matrix/metabolism , Extracellular Matrix/physiology , Extracellular Matrix Proteins/metabolism , Gene Expression Regulation, Developmental , Glycoproteins/metabolism , Hyaluronan Receptors/metabolism , Intercellular Signaling Peptides and Proteins , Membrane Glycoproteins/genetics , Mice , Mice, Inbred C57BL , Osteoblasts/cytology , Osteoblasts/metabolism , Osteocytes/cytology , Osteocytes/drug effects , Osteocytes/metabolism , PHEX Phosphate Regulating Neutral Endopeptidase/metabolism , Skull/cytology , Skull/growth & development
13.
Nat Med ; 18(3): 405-12, 2012 Feb 19.
Article in English | MEDLINE | ID: mdl-22344299

ABSTRACT

The signaling molecule Wnt regulates bone homeostasis through ß-catenin-dependent canonical and ß-catenin-independent noncanonical pathways. Impairment of canonical Wnt signaling causes bone loss in arthritis and osteoporosis; however, it is unclear how noncanonical Wnt signaling regulates bone resorption. Wnt5a activates noncanonical Wnt signaling through receptor tyrosine kinase-like orphan receptor (Ror) proteins. We showed that Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhanced osteoclastogenesis. Osteoblast-lineage cells expressed Wnt5a, whereas osteoclast precursors expressed Ror2. Mice deficient in either Wnt5a or Ror2, and those with either osteoclast precursor-specific Ror2 deficiency or osteoblast-lineage cell-specific Wnt5a deficiency showed impaired osteoclastogenesis. Wnt5a-Ror2 signals enhanced receptor activator of nuclear factor-κB (RANK) expression in osteoclast precursors by activating JNK and recruiting c-Jun on the promoter of the gene encoding RANK, thereby enhancing RANK ligand (RANKL)-induced osteoclastogenesis. A soluble form of Ror2 acted as a decoy receptor of Wnt5a and abrogated bone destruction in mouse arthritis models. Our results suggest that the Wnt5a-Ror2 pathway is crucial for osteoclastogenesis in physiological and pathological environments and represents a therapeutic target for bone diseases, including arthritis.


Subject(s)
Osteoblasts/metabolism , Osteoclasts/metabolism , Receptor Tyrosine Kinase-like Orphan Receptors/metabolism , Wnt Proteins/metabolism , Wnt Signaling Pathway , Animals , Arthritis/metabolism , Bone Diseases/metabolism , Cell Lineage , Gene Expression Regulation , MAP Kinase Kinase 4/metabolism , Mice , Osteoblasts/cytology , Osteoclasts/cytology , Promoter Regions, Genetic , Proto-Oncogene Proteins c-jun/genetics , Proto-Oncogene Proteins c-jun/metabolism , Receptor Activator of Nuclear Factor-kappa B/genetics , Receptor Activator of Nuclear Factor-kappa B/metabolism , Receptor Tyrosine Kinase-like Orphan Receptors/deficiency , Receptor Tyrosine Kinase-like Orphan Receptors/genetics , Skull/cytology , Skull/growth & development , Wnt Proteins/deficiency , Wnt Proteins/genetics , Wnt-5a Protein , X-Ray Microtomography
14.
Homo ; 62(1): 56-67, 2011 Feb.
Article in English | MEDLINE | ID: mdl-21238961

ABSTRACT

Various explanations have been formulated regarding high levels of craniofacial variation among Native American populations but the contribution of developmental processes to the establishment of these patterns of variation remains unknown. In this study, we compare facial morphology in ontogenetic series of three Native South American populations, one hunter-gatherer group and two farmer groups, in order to test the null hypothesis that indicates that the pattern of facial differentiation between populations does not change during ontogeny. If diet-related factors contribute to outline facial morphology, it is likely to find greater differences between hunter-gatherer and both farmer groups than between two groups of farmers and this differentiation is expected to increase with age, especially in those structures that are influenced by the mechanical load of mastication. According to our results, hunter-gatherers clearly differ from the two groups of farmers. Non-heritable factors linked to diet, such as nutritional content of food, may increase differentiation across ontogeny in some cases. However, as hunter-gatherers were clearly separated from farmer populations during entire postnatal ontogeny, an important proportion of size variation may not necessarily reflect eco-sensitive changes. Consequently, the hypothesis cannot be completely rejected.


Subject(s)
Facial Bones/anatomy & histology , Indians, South American/history , Analysis of Variance , Argentina , Cephalometry , Diet , Facial Bones/growth & development , Female , Fossils , History, Ancient , Humans , Male , Skull/anatomy & histology , Skull/growth & development
15.
Anat Histol Embryol ; 38(5): 392-9, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19769572

ABSTRACT

Lead exposure during intrauterine life was found to result in reduced birth weight, impaired skeletal development and post-natal neurotoxic effects. In this study, the effect of pre-natal exposure to different doses of lead on the development of craniofacial skeleton in rat fetuses was investigated. Vitamin E was tested as a concomitant treatment, aiming to improve the fetotoxic effects of lead. Positively pregnant female rats were randomly divided into four groups; groups I and II (L250 and L500), exposed to lead acetate in doses of 250 and 500 mg/l respectively, group III (L500 + E), exposed to lead acetate (500 mg/l) wit concomitant vitamin E and group IV (Control) which was given sodium acetate only. All the treatments started from the first day of gestation till the 20th day, where all rats were sacrificed and the fetuses were recovered. Fetuses were processed to alizarin red staining for ossified components. Twenty-seven bones of the craniofacial skeleton were studied in each fetus where the ossification was scored as being complete, delayed or absent. In all studied fetuses from all groups, changes were found only in eight bones while the remaining craniofacial bones were normally ossified. In affected bones there was a significant decrease in the number of completely ossified bones; associated with a significant increase of both partially ossified and absent bones in L(250) and L(500) treated groups when compared to the control group. These differences were more significant in the L(500) treated group. Giving vitamin E improved the percentage of completely ossified craniofacial bones and decreased the percentage of both partially ossified and absent bones. The most affected bone was presphenoid, then to a lesser extent supraoccipital, squamosal, parietal, interparietal and frontal bone respectively. In conclusion, lead exposure to rats during pregnancy led to varying degrees of fetal growth retardation as well as delayed ossification of some craniofacial bones which were dose dependent and the concomitant supplementation with vitamin E greatly improved the deleterious effect of lead.


Subject(s)
Antioxidants/pharmacology , Craniofacial Abnormalities/chemically induced , Fetus/abnormalities , Fetus/drug effects , Organometallic Compounds/toxicity , Vitamin E/pharmacology , Animals , Drug Administration Schedule , Female , Osteogenesis/drug effects , Pregnancy , Rats , Skull/abnormalities , Skull/drug effects , Skull/growth & development , Vitamin E/administration & dosage
16.
Ital J Anat Embryol ; 114(4): 167-78, 2009.
Article in English | MEDLINE | ID: mdl-20578673

ABSTRACT

The work reports morphometric analysis of the skulls of the Sahel breed of goat. The calculated metric data (mean +/- SD) included the condylobasal length, 16.94 +/- 1.39 cm, while the orbital circumference was 11.30 +/- 0.48 cm. The foramen magnum height and width were 1.82 +/- 0.11 cm and 1.85 +/- 0.15 cm respectively while the foramen magnum index was 89.81 +/- 8.71. Animals above one year of age had significantly higher values for orbital length including horizontal and vertical diameters, overall skull length, basal length, and neurocranium height than animals aged one year and below. The cornual process length, maximum orbital circumference and horizontal diameter obtained in this study were higher than those reported for other Nigerian goat breeds in the literature. The data for the distances from the facial tuberosity to the infraorbital canal, from the mental foramen to the lateral extent of the alveolar root of the lower incisor, as well as from the mandibular foramen to the base of the mandible and that from the mental foramen to the caudal border of the mandible, which are important clinically in the estimation of craniofacial measurements that will aid regional anaesthesia, were however similar to those reported earlier for the Red Sokoto and West African Dwarf breeds implying that a uniform craniometric estimation for associated regional nerve blocks can be attempted for these goat breeds.


Subject(s)
Cephalometry/methods , Goats/anatomy & histology , Skull/anatomy & histology , Adaptation, Physiological/physiology , Aging/physiology , Anatomy, Comparative/methods , Anesthesia, Local/standards , Animals , Biomarkers , Dwarfism , Female , Foramen Magnum/anatomy & histology , Foramen Magnum/growth & development , Genetic Variation/physiology , Goats/growth & development , Male , Mandible/anatomy & histology , Mandible/growth & development , Nerve Block/standards , Nigeria , Skull/growth & development , Species Specificity , Trigeminal Nerve/anatomy & histology , Trigeminal Nerve/growth & development
17.
Rev Laryngol Otol Rhinol (Bord) ; 127(5): 275-84, 2006.
Article in French | MEDLINE | ID: mdl-17425001

ABSTRACT

The hominisation of the skull comes with the bipedic posture, due to a network of muscular and aponevrotic forces applied to the cranio-facial skeleton. A brief sight of the morphogenetic origine and issues of these forces help to understand more clearly the postural statement of the larynx, his functions, and his many extrinsic biomechanical bounds; then further his most frequently dysfunctions. The larynx is surrounded by several effective systems of protection: active, activo-passive, passive. The architectural features of the components of the laryngeal system allows us to consider the laryngeal function as an auto-balanced system. All the forces engaged are auto-balanced in a continuum of tension. This lead us to the concept of tensegrity system, neologism coming from tensional integrity described by Buckminster Fuller. The laryngeal employement by extrinsic system is pathological in case of chronicity. Any osteopathic treatment, which aims to restore the losses of laryngeal mobility, has to release first the peripherical structures involved in the laryngeal defense, before normalising the larynx itself Finally, the larynx recovers his functions in a tensegrity system.


Subject(s)
Laryngeal Muscles/physiology , Larynx/physiology , Posture/physiology , Voice Disorders/physiopathology , Voice/physiology , Adult , Animals , Biological Evolution , Biomechanical Phenomena , Child , Child, Preschool , Deglutition/physiology , Humans , Infant, Newborn , Laryngeal Muscles/anatomy & histology , Laryngeal Muscles/physiopathology , Laryngoscopy , Larynx/anatomy & histology , Larynx/growth & development , Morphogenesis , Phylogeny , Pressure , Skull/growth & development
18.
J Cell Physiol ; 202(1): 255-62, 2005 Jan.
Article in English | MEDLINE | ID: mdl-15389522

ABSTRACT

Retinoic acid has been shown to adversely affect craniofacial development. Cleft palate and craniosynostosis are two examples of craniofacial defects associated with prenatal exposure to this agent. Although the effects of retinoic acid on cephalic neural crest-derived tissues have previously been studied, the specific effects of retinoic acid on the cellular biology of osteoblasts remain unclear. The purpose of this study was to analyze in detail the effects of pharmacologic doses of retinoic acid on the differentiation and proliferation of osteoblasts derived from an intramembranous source. Primary rat calvarial osteoblasts were established in culture and treated with 1 or 10 microM all-trans-retinoic acid. Retinoic acid treatment markedly increased expression of osteopontin up to 48 h after stimulation. Consistent with this early stage of differentiation, both mRNA and protein analysis of FGF receptor isoforms demonstrated a switch in predominance from fibroblast growth factor receptor 2 (fgfr2) to fgfr1. Analysis of PCNA protein confirmed inhibition of proliferation by retinoic acid. To determine whether these alterations in osteoblast biology would lead to increased differentiation, we examined short term [alkaline phosphatase (AP) activity] and long term (von Kossa staining) surrogates of bone formation in vitro. These assays confirmed that retinoic acid increased osteogenesis, with a 4-fold increase in bone nodule formation in cells treated with 10 microM retinoic acid after 28 days. Overall, our results demonstrated that pharmacologic doses of all-trans-retinoic acid decreased osteoblast proliferation and increased differentiation, suggesting that retinoic acid may effect craniofacial development by pathologically enhancing osteogenesis.


Subject(s)
Maxillofacial Abnormalities/chemically induced , Maxillofacial Development/drug effects , Osteoblasts/drug effects , Skull/drug effects , Tretinoin/pharmacology , Alkaline Phosphatase/drug effects , Alkaline Phosphatase/physiology , Animals , Animals, Newborn , Cell Differentiation/drug effects , Cell Differentiation/physiology , Cell Proliferation/drug effects , Cells, Cultured , Dose-Response Relationship, Drug , Female , Maxillofacial Abnormalities/metabolism , Maxillofacial Abnormalities/physiopathology , Maxillofacial Development/physiology , Osteoblasts/metabolism , Osteopontin , Pregnancy , Prenatal Exposure Delayed Effects , Proliferating Cell Nuclear Antigen/drug effects , Proliferating Cell Nuclear Antigen/metabolism , Rats , Rats, Sprague-Dawley , Receptor Protein-Tyrosine Kinases/drug effects , Receptor Protein-Tyrosine Kinases/metabolism , Receptor, Fibroblast Growth Factor, Type 1 , Receptor, Fibroblast Growth Factor, Type 2 , Receptors, Fibroblast Growth Factor/drug effects , Receptors, Fibroblast Growth Factor/metabolism , Sialoglycoproteins/drug effects , Sialoglycoproteins/metabolism , Skull/cytology , Skull/growth & development , Up-Regulation/drug effects , Up-Regulation/physiology
19.
Endocrinology ; 145(9): 4366-74, 2004 Sep.
Article in English | MEDLINE | ID: mdl-15166119

ABSTRACT

Lactoferrin is an iron-binding glycoprotein present in epithelial secretions, such as milk, and in the secondary granules of neutrophils. We found it to be present in fractions of milk protein that stimulated osteoblast growth, so we assessed its effects on bone cell function. Lactoferrin produced large, dose-related increases in thymidine incorporation in primary or cell line cultures of human or rat osteoblast-like cells, at physiological concentrations (1-100 microg/ml). Maximal stimulation was 5-fold above control. Lactoferrin also increased osteoblast differentiation and reduced osteoblast apoptosis by up to 50-70%. Similarly, lactoferrin stimulated proliferation of primary chondrocytes. Purified, recombinant, human, or bovine lactoferrins had similar potencies. In mouse bone marrow cultures, osteoclastogenesis was dose-dependently decreased and was completely arrested by lactoferrin, 100 microg/ml, associated with decreased expression of receptor activator of nuclear factor-kappaB ligand. In contrast, lactoferrin had no effect on bone resorption by isolated mature osteoclasts. Lactoferrin was administered over calvariae of adult mice for 5 d. New bone formation, assessed using fluorochrome labels, was increased 4-fold by a 4-mg dose of lactoferrin. Thus, lactoferrin has powerful anabolic, differentiating, and antiapoptotic effects on osteoblasts and inhibits osteoclastogenesis. Lactoferrin is a potential therapeutic target in bone disorders such as osteoporosis and is possibly an important physiological regulator of bone growth.


Subject(s)
Lactoferrin/pharmacology , Osteoblasts/cytology , Osteoblasts/drug effects , Animals , Apoptosis/drug effects , Bone Marrow Cells/cytology , Bone Marrow Cells/drug effects , Cartilage/cytology , Cartilage/growth & development , Cattle , Cell Differentiation/drug effects , Cell Division/drug effects , Chondrocytes/cytology , Chondrocytes/drug effects , Cricetinae , Humans , Kidney/cytology , Male , Mice , Milk/chemistry , Milk, Human/chemistry , Organ Culture Techniques , Osteoclasts/cytology , Osteoclasts/drug effects , Rats , Skull/cytology , Skull/growth & development
20.
Pharmazie ; 59(1): 61-4, 2004 Jan.
Article in English | MEDLINE | ID: mdl-14964424

ABSTRACT

The flavonoid extract from Epimedium sagittatum (FES) has been found by us to be effective in preventing osteoporosis induced by ovariectomy in rats. In the present study, the effect of FES on the development of rat calvarial osteoblast-like (ROB) cells was investigated. No appreciable effect was observed when ROB cells were exposed to FES in vitro. However, serum isolated from rats administered FES orally was able to significantly stimulate the proliferation as well as the osteoblastic differentiation of ROB cells compared to serum from control rats. The results indicate that the serum of rats administered FES contains active metabolites ofFES that enhance the development of osteoblasts, while the original form of FES itself is inactive.


Subject(s)
Epimedium/chemistry , Flavonoids/pharmacology , Osteoblasts/drug effects , Skull/drug effects , Alkaline Phosphatase/metabolism , Animals , Animals, Newborn , Calcification, Physiologic/drug effects , Calcium/metabolism , Cell Differentiation/drug effects , Cell Division/drug effects , Cells, Cultured , Flavonoids/chemistry , Osteocalcin/metabolism , Osteoporosis/pathology , Plant Extracts/chemistry , Plant Extracts/pharmacology , Rats , Rats, Wistar , Skull/cytology , Skull/growth & development
SELECTION OF CITATIONS
SEARCH DETAIL